• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    BIMI Announces Appointment of New Chairman and Independent Director

    5/18/22 8:30:00 AM ET
    $BIMI
    Other Pharmaceuticals
    Health Care
    Get the next $BIMI alert in real time by email

    NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), a healthcare products and services provider, today announced that on May 12, 2022, the Board of Directors of the Company appointed Mr. Fnu Oudom to serve as Chairman of the Board and President of the Company, effective immediately. On May 12, 2022, the Board also elected Ms. Sammi Earn Seok Ang as an independent director of the Company, effective immediately.

    "Recruiting new directors to improve diversity and provide global perspective to the Board is a recently initiated action to enhance BIMI's corporate governance. We believe our new chairman's leadership and connections will bring positive changes to the Company," said Mr. Tiewei Song, Chief Executive Officer of the Company.

    "I am grateful for the confidence that the Board of Directors has shown in me. I am honored to be part of the next stage of development of BIMI," said Mr. Fnu Oudom, Chairman and President of the Company. "We plan to refocus our business on the US market and to make new investments in the United States. I look forward to working closely with the Board to meet the exciting challenges we face," concluded Mr. Oudom.

    About Mr. Fnu Oudom

    Mr. Fnu Oudom has worked at FCCC Inc., a US company focused on strategic investments and acquisitions in a variety of industries, since April 2021. He was Chairman of the Board of the Time Chain Group, a pharmaceutical and nutritional product research & development and distribution company, from March 2015 to March 2021. From May 2018 to December 2020, he was the Representative of Vanuatu to the United Nations Economic and Social Council for Asia and the Pacific, dedicated to promoting higher standards of living, economic and social progress for the island country. From April 2014 to April 2016, he was the Representative of Tuvalu to the United Nations Economic and Social Council for Asia and the Pacific, focused on the promotion of the island country's social economic development and facilitation of the island country's cultural and educational exchange with other member countries. From September 1998 to March 2014, he was the President of Suranaree Industrial Zone, LTD in Thailand, leading the establishment and development of the industrial zone.

    Mr. Oudom studied as a postgraduate at the Institute of Political Science and Law at the French Academy of Social Sciences in Paris from Sept 1989 to May 1995 and served as a visiting professor at Taiwan Mingdao University in 2014. He received his Bachelor's degree in Philosophy from Sichuan University in China.

    About Ms. Sammi Earn Seok Ang

    Ms. Seok Ang has worked at Pacific Rainbow International In, as a buyer of dietary nutritional raw materials since October 2017. From December 2013 to May 2016, she worked at M/A-COM Technology Solutions Holdings, Inc. as a logistics analyst. From December 2012 to December 2013, she worked at Mindspeed Technologies, Inc., a semiconductor manufacturer as a buyer/planner. From February 2012 to July 2012, she worked at Paper Mart, an industrial & retail packaging company as a buyer. From January 2008 to July 2010, she worked at RJ Sports, a soft goods importer and wholesaler/manufacturer of golf bags and accessories as a product manager. Ms. Seok Ang holds two Bachelor's degrees in International Business – Management and in Computer Information Systems Track – Client-Server and a Master's degree in Business Administration – Logistics and Transportation from Missouri State University.

    About BIMI International Medical Inc.

    BIMI International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and services provider, offering a broad range of healthcare products and related services and operates five private hospitals in China. For more information, please visit www.usbimi.com.

    Safe Harbor Statement

    Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company's ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company's products and services in the People's Republic of China, general economic conditions and other risk factors detailed in the Company's annual report and other filings with the United States Securities and Exchange Commission.

    IR Contact:

    Dragon Gate Investment Partners LLC

    Tel: +1(646)-801-2803

    Email: [email protected]



    Get the next $BIMI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BIMI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BIMI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by BIMI International Medical Inc. (Amendment)

      SC 13D/A - BIMI Holdings Inc. (0001213660) (Subject)

      1/11/24 4:46:28 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13D/A filed by BIMI International Medical Inc. (Amendment)

      SC 13D/A - BIMI International Medical Inc. (0001213660) (Subject)

      12/19/23 4:01:04 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13D filed by BIMI International Medical Inc.

      SC 13D - BIMI International Medical Inc. (0001213660) (Subject)

      8/8/22 4:45:19 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care

    $BIMI
    Financials

    Live finance-specific insights

    See more
    • BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results

      NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) --  BIMI International Medical Inc. (the "Company"), a leading medical solutions provider, today announced its financial results for the three months and nine months ended September 30, 2023. Revenues for the three months ended September 30, 2023 and 2022 were $2,523,193 and $4,932,479, respectively. Revenues for the nine months ended September 30, 2023 and 2022 were $11,278,496 and $10,476,224, respectively. The revenues of the Zhongshan, Qiangsheng, Eurasia, and Minkang hospitals, that are held for sale, were accounted for separately. Net loss for the three months ended September 30, 2023 and 2022 was $3,134,072 and $3,099,662, respectively, whi

      12/19/23 8:01:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results

      NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the "Company"), a leading medical solutions provider, today announced its financial results for the three months ended June 30, 2023. The Company reported a significant increase in gross margin underlining the ongoing success of its business strategy and operational effectiveness. Revenues for the six months ended June 30, 2023 and 2022 were $8,755,303 and $5,543,745, respectively. Compared with the same period in 2022, revenue increased by $3,211,558, due to the inclusion of the revenues of Phenix Bio Inc., which was acquired on March 15, 2023. The revenues of the Zhongshan, Qiangsheng, Eurasia, and Minkang h

      11/27/23 8:25:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. Announces First Quarter 2023 Financial Results

      NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the "Company"), a leading medical solutions provider, today announced its financial results for the three months ended March 31, 2023. The Company reported a significant decrease in net losses and notable improvements in working capital, underlining the ongoing success of its business strategy and operational effectiveness. Revenues for the three months ended March 31, 2023 and 2022 were $3,197,637 and $2,714,711, respectively. The revenues for the three months ended March 31, 2023 were primarily attributable to the revenues from sales of healthcare products by Phenix Bio Inc., a newly acquired subsidiary, and  fr

      5/22/23 9:25:53 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care

    $BIMI
    Leadership Updates

    Live Leadership Updates

    See more
    • BIMI Announces Results of 2023 Annual General Meeting of Stockholders

      New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company's 2022 Annual General Meeting of Stockholders (the "Annual Meeting") held on Dec 29, 2023 at 11:00 a.m. at the offices of the Company, 725 5th Ave, New York, NY 10022. At the Annual General Meeting the shareholders voted and approved; 1. The election of seven directors to serve on the board of directors of the Company, until the next annual meeting of Stockholders and until their respective successors have been duly elected and quali

      1/3/24 7:00:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor

      NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ:BIMI, "BIMI"))), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company ("Hao Mu"), as its exclusive distributor responsible for the distribution of Phenix's 17 herbal supplements in Hong Kong, Taiwan and Macau. Pursuant to the terms of a sales agreement entered into on October 29, 2023, Hao Mu must make annual purchases of at least $5 million in order to maintain its exclusive distributor status for this territory. Under the terms of this agreement, Phenix's comprehensive portfolio of high-quality herbal su

      10/30/23 9:29:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Mainland China Non-Exclusive Distributor

      NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ:BIMI, "BIMI"))), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company ("Hao Mu"), as a distributor responsible for the distribution of Phenix's 17 herbal supplements in Mainland China. Pursuant to the terms of a sales agreement entered into on October 29, 2023, Hao Mu must make annual purchases of at least $5 million in order to maintain its distributor status for this territory. Under the terms of this agreement, Phenix's comprehensive portfolio of high-quality herbal supplements will be made available to co

      10/30/23 9:27:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care

    $BIMI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Oudom Fnu was granted 1,123,500 shares, increasing direct ownership by 285% to 1,518,243 units (SEC Form 4)

      4 - BIMI Holdings Inc. (0001213660) (Issuer)

      6/13/24 1:06:18 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • New insider Smith Symington Wei claimed ownership of 3,456 shares (SEC Form 3)

      3 - BIMI Holdings Inc. (0001213660) (Issuer)

      3/20/24 8:04:41 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • Tiewei Song sold $2,903 worth of shares (724 units at $4.01), decreasing direct ownership by 0.21% to 341,117 units (SEC Form 4)

      4 - BIMI Holdings Inc. (0001213660) (Issuer)

      3/4/24 4:03:12 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care

    $BIMI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq

      New York, May 20, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on May 17, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising the Company that due to its failure to timely file its Form 10-Q for the period ended March 31, 2024, with the Securities and Exchange Commission (the "SEC"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended December 31, 2023, it is not in compliance with Nasdaq's contin

      5/20/24 4:09:46 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq

      New York, April 23, 2024 (GLOBE NEWSWIRE) --  BIMI Holdings Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on April 19, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising the Company that due to the Company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, with the Securities and Exchange Commission (the "SEC"), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (

      4/23/24 4:05:00 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI Announces Results of 2023 Annual General Meeting of Stockholders

      New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company's 2022 Annual General Meeting of Stockholders (the "Annual Meeting") held on Dec 29, 2023 at 11:00 a.m. at the offices of the Company, 725 5th Ave, New York, NY 10022. At the Annual General Meeting the shareholders voted and approved; 1. The election of seven directors to serve on the board of directors of the Company, until the next annual meeting of Stockholders and until their respective successors have been duly elected and quali

      1/3/24 7:00:00 AM ET
      $BIMI
      Other Pharmaceuticals
      Health Care

    $BIMI
    SEC Filings

    See more
    • BIMI International Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - BIMI Holdings Inc. (0001213660) (Filer)

      7/29/24 4:01:18 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. filed SEC Form 8-K: Leadership Update

      8-K - BIMI Holdings Inc. (0001213660) (Filer)

      6/4/24 4:30:41 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care
    • BIMI International Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - BIMI Holdings Inc. (0001213660) (Filer)

      5/24/24 4:01:39 PM ET
      $BIMI
      Other Pharmaceuticals
      Health Care